Pharmaceutical / Drug Definition :
Suppresses dihydrotestosterone levels by inhibiting the hepatic enzyme 5-alpha reductase, which converts testosterone to dihydrotestosterone in prostate, liver, and skin
FDA Detentions
Finasteride (Finasteride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Finasteride (Finasteride Suppliers)
- Processors Finasteride
- Repackers Finasteride
- Relabelers Finasteride
- Exporters Finasteride
- Importers Finasteride
For more information about Finasteride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
